33 results
8-K
EX-99.1
CRNX
Crinetics Pharmaceuticals Inc
25 May 22
Regulation FD Disclosure
7:02am
, Safety Phase 1 Healthy Volunteer Safety, Pharmacologic POC ∆Hormones, PK, Safety Phase 2,3 Safety, Disease Efficacy ∆Hormones, PROs, PK, Safety Phase 1 … et al. Lancet Diab Endo 7:300-12, 2019. Castinetti JCEM 99: 1623-1639, 2014. Castinetti JCEM 106: 2114-2123, 2021. ACTH
CRN04894 Healthy Volunteer
8-K
EX-99.2
CRNX
Crinetics Pharmaceuticals Inc
18 Dec 23
Crinetics Announces Positive Initial Findings from Ongoing Open-Label Phase 2 Study of Paltusotine for the Treatment of Carcinoid Syndrome
4:12pm
Exposure in Patients with Carcinoid Syndrome was Consistent with Expectations from Healthy Volunteers Healthy volunteer data is from paltusotine … -dose, 80 mg trough, and 80 mg post-dose, respectively. Healthy Volunteer Carcinoid Syndrome Patients
Paltusotine was Well-Tolerated with No Severe
8-K
CRNX
Crinetics Pharmaceuticals Inc
17 Mar 22
Other Events
6:22pm
to announce data from the multiple ascending dose cohorts of its Phase 1 healthy volunteer study of CRN04777 by the end of the first quarter of 2022
8-K
CRNX
Crinetics Pharmaceuticals Inc
4 Feb 21
Other Events
7:00am
conditions of ACTH excess, such as CAH. Crinetics believes that, if successful, this healthy volunteer study can provide important clinical proof
8-K
CRNX
Crinetics Pharmaceuticals Inc
6 Apr 20
Regulation FD Disclosure
4:35pm
;0.001). Paltusotine washed out in a time frame consistent with the approximately2-day half-life previously measured in a healthy volunteer study
8-K
EX-99.1
89epm8 v4zeyu3d
8 May 24
Crinetics Pharmaceuticals to Present Advancements from Atumelnant (CRN04894) and Paltusotine Development Programs at ENDO 2024
5:00pm
8-K
EX-99.1
9o12xr7ceecpme7 j0w0
12 Aug 22
Crinetics Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:41am
8-K
EX-99.1
xrpdwyuq jsi
6 May 21
Crinetics Pharmaceuticals Reports First Quarter 2021 Financial Results
4:01pm
8-K
EX-99.1
1e85szs12g lm
14 Nov 22
Crinetics Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
8:15am
8-K
EX-99.1
yr1lx6
12 May 22
Crinetics Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:40pm
8-K
EX-99.1
j9zfjd20he h5
5 Nov 21
Crinetics Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
8:00am
8-K
EX-99.2
a2fjjrm hl7go
10 Aug 21
Crinetics Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:05pm
8-K
EX-99.2
qvyn263jomt2eggy7
30 Mar 22
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm